​​Pharmacy Roundup: This Week’s Top 5 Articles for May 26, 2023 

Every week we share our favorite articles that other organizations, associations, and companies are producing to help your pharmacy business thrive.

You’ll discover new strategies and tips to boost your independent community pharmacy business and to stay up to date on what’s happening in the pharmacy industry.

This week we chose five articles covering topics from a new nasal spray for emergency opioid overdose to a skin patch for toddlers with peanut allergy. 

Stress Hormone Found in Hair May Indicate Higher Heart Disease Risk

According to researchers, a stress hormone found in hair samples might help predict who’s at a higher risk of cardiovascular disease. The association seemed to be strongest among younger adults. MedicalNewsToday has the full story.

FDA Approves Nasal Spray for Emergency Opioid Overdose Treatment

The FDA granted approval of nalmefene (Opvee; Indivior PLC). This is the first nalmefene hydrochloride nasal spray for the emergency treatment of opioid overdose in patients 12 and older. Learn more by visiting Drug Topics.

Biosimilar Infliximab-dyyb as Effective as Remicade in Pediatric Patients

A study published in the Journal of Pediatric Gastroenterology and Nutrition revealed the biosimilar agent infliximab-dyyb (Inflectra; Pfizer) was found to be as effective as infliximab (Remicade; Janssen Immunology) for maintenance therapy in children with inflammatory bowel disease (IBD). Hop onto PharmacyTimes for the whole story.

Promising Skin Patch for Toddlers with Peanut Allergy

A global phase 3 clinical trial found that a year-long immunotherapy through a skin patch safely desensitized toddlers with peanut allergy by lowering the risk of severe allergic reaction from accidental exposure. Find more information on this story by visiting ScienceDaily.

Reluctant Parents Citing Safety as Reason for HPV Vaccine Hesitancy

The proportion of parents who say safety is the reason they’re hesitant to give their their adolescent children the human papillomavirus (HPV) vaccine increased from 2010 to 2018, according to a study in Pediatrics published online May 23. “Not necessary,” “safety concerns,” “lack of recommendation,” “lack of knowledge,” and “not sexually active” were the most frequently cited reasons for not intending to vaccinate. MPR has the full story.

A Member-Owned Company Serving Independent Pharmacies

PBA Health is dedicated to helping independent pharmacies reach their full potential on the buy-side of their business. Founded and owned by pharmacists, PBA Health serves independent pharmacies with group purchasing services, wholesaler contract negotiations, proprietary purchasing tools, and more.

An HDA member, PBA Health operates its own NABP-accredited secondary wholesaler with more than 6,000 SKUs, including brands, generics, narcotics CII-CV, cold-storage products, and over-the-counter (OTC) products—offering the lowest prices in the secondary market.

Editor’s Picks


Elements is written and produced by PBA Health, a buy-side solutions company.

Sign up for a FREE subscription to Elements magazine!


Sign up to receive PBA Health’s e-newsletter to get the latest Elements web articles in your inbox every other week, along with industry news, supply chain insights, and exclusive offers.

Related Articles

Popular Articles